India has issued first official guidelines for expert panels to bring consistency, speed, and transparency to drug and device ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best medical stocks to buy according to analysts. Bristol-Myers ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...

Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...

Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...

Sanofi will acquire rights to develop and commercialize the drug for $130 million upfront, with Visirna eligible for up to $265 million in milestone payments.

Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, ...

Smart contact lenses use tear biomarkers for real-time disease detection and drug delivery, offering a non-invasive future ...

President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...

Certain types of lipids resist being crowded, while others can get shoved in as tight as sardines. And the packing density is ...